FOXO1 and familial dilated cardiomyopathy: Furthermore, in the future, the upregulated activity of forkhead box O1 transcription factor (FoxO1) in DCM as studied from preclinical models (Shafaati and Gopal, 2024) would need further evaluation for biomarker and therapeutic targets in the clinical studies of DCM.